Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ChinaTranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms
- Where
- Hangzhou, Shaoxing
- Age
- 18 years and over
- People
- 394
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06643689 - Phase 1/2Taking peopleTIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
- Where
- Beijing
- Age
- 16 years to 90 years
- People
- 75
- Run by
- Essen Biotech
See details and how to joinNCT06532799 - Phase 2Taking peopleStudy of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 35
- Run by
- Peking University
See details and how to joinNCT06684600 - No phaseTaking peopleComparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 212
- Run by
- Xijing Hospital of Digestive Diseases
See details and how to joinNCT05356520 - Phase 2Not yet taking people in ChinaCadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)
- Where
- Shijiazhuang
- Age
- 18 years and over
- People
- 51
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT06681285 - Phase 2Taking peopleNeoantigen Vaccines in Esophageal Squamous Cell Carcinoma
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 165
- Run by
- Sichuan University
See details and how to joinNCT06675201 - Phase 2Not yet taking people in ChinaSHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
- Where
- Shenyang
- Age
- 18 years to 75 years
- People
- 28
- Run by
- Yunpeng Liu
See details and how to joinNCT06666166 - Phase 2Taking peopleAdebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Tang-Du Hospital
See details and how to joinNCT06663059 - No phaseTaking peopleIMmune Proteomics to Predict neoAdjuvant Chemotherapy and immunoTherapy Response in Gastric Cancer
- Where
- Xuhui District
- Age
- 18 years to 75 years
- People
- 206
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06662110 - Phase 2Taking peopleFruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma
- Where
- Shijiazhuang
- Age
- 18 years and over
- People
- 67
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT06646588 - No phaseTaking peopleRight Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 236
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06644352 - No phaseTaking peopleMulti-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
- Where
- Nanjing
- Age
- 18 years and over
- People
- 222
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05508126 - No phaseTaking peopleAI-Assisted Non-Contrast CT for Multi-Cancer Screening
- Where
- Shanghai
- Age
- 18 years and over
- People
- 1,000,000
- Run by
- Guo ShiWei
See details and how to joinNCT06632886 - Phase 3Taking peopleAdjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Zhengzhou
- Age
- 18 years to 70 years
- People
- 219
- Run by
- Henan Cancer Hospital
See details and how to joinNCT05495152 - Phase 1Not yet taking people in ChinaA PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
- Where
- Beijing, Beijjing
- Age
- 18 years and over
- People
- 112
- Run by
- Danatlas Pharmaceuticals Co., Ltd
See details and how to joinNCT06614751 - Phase 2Taking peopleEfficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 194
- Run by
- Xijing Hospital
See details and how to joinNCT06586242 - Phase 2Taking peopleThe Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 50
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06587425 - No phaseTaking peopleThe Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
- Where
- Shanghai
- Age
- 18 years and over
- People
- 30
- Run by
- Ruijin Hospital
See details and how to joinNCT06597526 - No phaseTaking peopleNeoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
- Where
- Hefei
- Age
- 18 years to 75 years
- People
- 70
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06602843 - No phaseTaking peopleIndividualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
- Where
- Guangzhou
- People
- 50
- Run by
- Sun Yat-Sen University Cancer Center
See details and how to joinNCT06561178 - Phase 1/2Taking peopleDisitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 35
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06572319 - No phaseTaking peopleResearch on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 50
- Run by
- Hua Zhu
See details and how to joinNCT06429891 - Phase 3Taking peopleSintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 40
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06563869 - Phase 2Taking peopleDisitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06560528 - Phase 2Taking peopleA Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
- Where
- Nanjing
- Age
- 75 years and over
- People
- 40
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06555471